Skip to content

Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)

Evaluating the Impact of Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03319030
Enrollment
43
Registered
2017-10-24
Start date
2017-09-01
Completion date
2018-09-30
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy

Keywords

exercise, Aerobic Exercise

Brief summary

This research study wants to learn more about Duchenne Muscular Dystrophy (DMD) and exercise. Today it is unknown how exercising impacts boys with DMD. The investigators believe that increasing activity and aerobic exercise may help with heart, lung, and muscle function. The investigators are hoping to compare physical strength and blood samples of boys with DMD to see if there are any differences between kids who exercised more as a child versus those who didn't.

Detailed description

Recently, the American Academy of Neurology released new guidelines for children with Duchenne Muscular Dystrophy (DMD) with an updated recommendation to include moderate aerobic exercise. Historically, children with DMD were advised to not exercise as it was thought to accelerate muscle loss. Today, there is new data suggesting that moderate aerobic exercise that does not strain muscle may be beneficial and improve a child's quality of life with regard to heart disease, fatigue, and other factors of overall health. Although it is expected that children who exercise will experience health benefits, there is no scientific evidence indicating a positive or negative effect in a DMD population. This study is trying to understand the role of aerobic exercise in boys with DMD and how it may impact heart, muscle, and lung function using newly identified biomarkers. The goal is to correlate increased aerobic exercise with improved functional outcomes and changes in biomarkers. The data collected from this study will allow future development and implementation of an innovative and disease-specific home aerobic exercise program that in the future will be recommended to families of children with DMD.

Interventions

None listed

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
2 Years to 17 Years

Inclusion criteria

* Ages 2-17 years old with a confirmed diagnosis of DMD. Has an appointment in MDA clinic at the Ann & Robert H. Lurie Children's Hospital of Chicago.

Exclusion criteria

* Is less than two years old and does not have a confirmed diagnosis of DMD.

Design outcomes

Primary

MeasureTime frameDescription
microRNA levelsBaseline onlyUnderstanding if there are any differences in microRNA's in boys who are more active versus those who are not.

Secondary

MeasureTime frameDescription
Physical therapy assessment - North Star Ambulatory AssessmentBaseline onlyComparing a standardized test for ambulatory boys with DMD that gives a score out of 34 total points and microRNA levels.
Physical therapy assessment - time to standing from supineBaseline onlyTime in seconds that it takes a participant to stand from a supine position.
Cardiac Assessments: Electrocardiogram (ECG)Baseline onlyComparing heart rate (BPM), PR interval (msec), QRS (msec), and QT intervals (msec) to microRNA levels.
Physical therapy assessment - 10 meter run testBaseline onlyTime in seconds that it takes a participant to run 10 meters.
Questionnaire: Pediatric Quality of Life: Neuromuscular moduleBaseline onlyTo see if there is any correlation between Quality of Life scores (range from 0 to 100) and microRNA levels. Increased scores indicate a higher quality of life.
Questionnaire: Physical Function SurveyBaseline onlyTo see if there is any correlation between scores of functional ability (with a range from 0 to 106) and microRNA levels. Higher physical function function scores indicate increased strength.
Cardiac Assessments: Echocardiogram (ECHO)Baseline onlyComparing ejection fraction (%) and other Left Ventricle systolic and diastolic metrics (cm) and microRNA levels.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026